Related Experiment Video
Updated: Sep 7, 2025

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
Published on: May 17, 2024
Predicting Progression from Gestational Diabetes to Impaired Glucose Tolerance Using Peridelivery Data: An
Angela M Bengtson1, Ana Lucia Espinosa Dice1, Melissa A Clark2,3
1Department of Epidemiology, Brown School of Public Health, Providence, Rhode Island.
A new model can predict postpartum impaired glucose tolerance in women with recent gestational diabetes mellitus (GDM). This tool uses eight clinical indicators to identify individuals needing targeted diabetes prevention strategies.
Area of Science:
- Endocrinology
- Reproductive Medicine
- Preventive Medicine
Background:
- Gestational diabetes mellitus (GDM) increases the risk of future type 2 diabetes and impaired glucose tolerance (IGT).
- Early identification of individuals at high risk for postpartum IGT is crucial for timely intervention.
Purpose of the Study:
- To develop and validate a predictive model for identifying individuals with recent GDM who are most likely to progress to IGT postpartum.
- To assess the predictive performance of the developed model using established statistical metrics.
Main Methods:
- An observational study followed 203 individuals with GDM through 1-year postpartum.
- Lasso regression with k-fold cross-validation was employed to build a multivariable predictive model.
- Model performance was evaluated using Area Under the Curve (AUC), sensitivity, specificity, PPV, and NPV.
Main Results:
- The final predictive model achieved an AUC of 0.79, indicating reasonable predictive ability.
- Key predictors included weight, BMI, family history of type 2 diabetes, prior GDM, early GDM diagnosis, and postpartum glucose levels.
- The model demonstrated 80% sensitivity and 85% NPV in identifying individuals with postpartum IGT.
Conclusions:
- The developed predictive model shows promise in identifying individuals with GDM at higher risk for postpartum IGT.
- The model's clinical utility could aid in prioritizing diabetes prevention efforts for at-risk populations.
- Further validation is recommended to confirm the model's generalizability and clinical impact.
More Related Videos
06:59Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
Published on: November 13, 2016
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Dipeptidyl Peptidase 4 Inhibitors
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...